Open Trial of Miglitol in Type 1 Diabetic Patients With Insulin Treatment
1 other identifier
interventional
N/A
1 country
7
Brief Summary
The purpose of this study is evaluate the clinical efficacy and safety of Miglitol in patients with Type1 Diabetes Mellitus treated with insulin.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 13, 2005
CompletedFirst Posted
Study publicly available on registry
September 21, 2005
CompletedSeptember 21, 2006
September 1, 2006
September 13, 2005
September 20, 2006
Conditions
Keywords
Interventions
Eligibility Criteria
You may qualify if:
- Type1 Diabetes
- Criteria of postprandial glucose and HbA1c are met
You may not qualify if:
- Type2 Diabetes
- Patients with antidiabetic drugs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (7)
Unknown Facility
Chiba, Japan
Unknown Facility
Fukuoka, Japan
Unknown Facility
Gifu, Japan
Unknown Facility
Ibaraki, Japan
Unknown Facility
Kanagawa, Japan
Unknown Facility
Kumamoto, Japan
Unknown Facility
Ōita, Japan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Clinical Promotion Group
Sanwa Kagaku Kenkyusho Co., Ltd.
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
September 13, 2005
First Posted
September 21, 2005
Last Updated
September 21, 2006
Record last verified: 2006-09